Harm Reduction Coalition Perspective on the HHS Action Plan Daniel Raymond Policy Director Harm Reduction Coalition www.ha...
Big Wins in the Plan <ul><li>Drug use chapter </li></ul><ul><li>HRSA involvement & FQHCs </li></ul><ul><li>Process & respo...
Strong syringe access language <ul><li>VHAP: </li></ul><ul><ul><li>In accordance with local laws, coordination of federal,...
Community Health Centers <ul><li>Promote HHS-recommended viral hepatitis testing as a standard of care in all federally sp...
Centers of Excellence <ul><li>At least 10 across the country </li></ul><ul><li>Targeted infusion of resources for surveill...
Where’s SAMHSA? <ul><li>Involved in interagency working group, referenced in the plan, CSAT Director Dr. Westley Clark att...
Where’s the money? <ul><li>Several areas reference Affordable Care Act funds & provisions </li></ul><ul><li>New: Community...
Opportunities <ul><li>Mechanisms for input, accountability & monitoring implementation </li></ul><ul><li>Standardizing too...
Upcoming SlideShare
Loading in …5
×

Harm reduction perspective on HHS Viral Hepatitis Action Plan

1,069 views

Published on

A harm reduction perspective on the U.S. Health & Human Services Dept. Viral Hepatitis Action Plan (http://www.hhs.gov/ash/initiatives/hepatitis/), presented for a Caring Ambassadors Program webinar (listen here: https://caringambassadors.ilinc.com/join/ppsmrth).

Published in: Health & Medicine
0 Comments
0 Likes
Statistics
Notes
  • Be the first to comment

  • Be the first to like this

No Downloads
Views
Total views
1,069
On SlideShare
0
From Embeds
0
Number of Embeds
215
Actions
Shares
0
Downloads
7
Comments
0
Likes
0
Embeds 0
No embeds

No notes for slide

Harm reduction perspective on HHS Viral Hepatitis Action Plan

  1. 1. Harm Reduction Coalition Perspective on the HHS Action Plan Daniel Raymond Policy Director Harm Reduction Coalition www.harmreduction.org [email_address]
  2. 2. Big Wins in the Plan <ul><li>Drug use chapter </li></ul><ul><li>HRSA involvement & FQHCs </li></ul><ul><li>Process & responsiveness to community input and engagement </li></ul><ul><li>Attention from hepatitis champions in Congress </li></ul>
  3. 3. Strong syringe access language <ul><li>VHAP: </li></ul><ul><ul><li>In accordance with local laws, coordination of federal, state, and local resources will reduce barriers, maximize development of syringe service programs, and increase access to these programs. </li></ul></ul><ul><li>National HIV/AIDS Strategy: </li></ul><ul><ul><li>CDC and SAMHSA will complete guidance for evidence-based comprehensive prevention, including syringe exchange and drug treatment programs, for injection drug users. </li></ul></ul>
  4. 4. Community Health Centers <ul><li>Promote HHS-recommended viral hepatitis testing as a standard of care in all federally sponsored primary-care programs (e.g., community health centers and IHS clinics). </li></ul><ul><li>Develop and implement performance measures for hepatitis testing in HHS-programs (e.g., community health centers, IHS clinics, and HIV test sites). </li></ul><ul><li>As part of Community Health Center and Ryan White CARE Act-funded programs, build a network of primary care physicians trained and equipped to provide prevention and care services for persons at risk for or infected with viral hepatitis. </li></ul><ul><li>Strengthen partnerships between community-based re-entry programs and community health centers to ensure that released inmates complete therapy for viral hepatitis. </li></ul>
  5. 5. Centers of Excellence <ul><li>At least 10 across the country </li></ul><ul><li>Targeted infusion of resources for surveillance, services, coordination </li></ul><ul><li>Potential platform for Hep B Free replication, syringe access expansion, etc. </li></ul><ul><li>Must have strong community role, accountability, partnerships </li></ul>
  6. 6. Where’s SAMHSA? <ul><li>Involved in interagency working group, referenced in the plan, CSAT Director Dr. Westley Clark attended launch </li></ul><ul><li>Draft revisions to SAMHSA Substance Abuse Prevention & Treatment Block Grant application & reporting don’t reference viral hepatitis </li></ul>
  7. 7. Where’s the money? <ul><li>Several areas reference Affordable Care Act funds & provisions </li></ul><ul><li>New: Community Transformation Grants include viral hepatitis as optional strategy for clinical preventive services </li></ul><ul><li>Defense of ACA & its components (Prevention & Public Health Fund) critical </li></ul>
  8. 8. Opportunities <ul><li>Mechanisms for input, accountability & monitoring implementation </li></ul><ul><li>Standardizing tools, data collection & sharing, and protocols </li></ul><ul><li>Strengthening collaboration between HBV & HCV advocacy communities </li></ul>

×